Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UK

OBJECTIVES: Budesonide/formoterol (BF) Spiromax(®) is an inhaled corticosteroid/long-acting β(2)-agonist fixed-dose combination (FDC) inhaler, designed to minimise common inhaler errors and provide reliable and consistent dose delivery in asthma and chronic obstructive pulmonary disease (COPD). We e...

全面介紹

Na minha lista:
書目詳細資料
發表在:BMJ Open
Main Authors: Voorham, Jaco, Roche, Nicolas, Benhaddi, Hicham, van der Tol, Marianka, Carter, Victoria, van Boven, Job F.M., Bjermer, Leif, Miravitlles, Marc, Price, David B
格式: Artigo
語言:Inglês
出版: BMJ Publishing Group 2018
主題:
Respiratory Medicine
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6224753/
https://ncbi.nlm.nih.gov/pubmed/30368448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2018-022051
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍